<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Acute myelocytic AND myelogenous leukemia (AML)</title><link>http://www.unboundmedicine.com/medline/ebm/research/Acute_myelocytic/myelogenous_leukemia_(AML)</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Establishment and characterization of a new human acute myelocytic leukemia cell line SH-2 with a loss of Y chromosome, a derivative chromosome 16 resulting from an unbalanced translocation between chromosomes 16 and 17, monosomy 17, trisomy 19, and p53 alteration.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18715689/full_citation/Establishment_and_characterization_of_a_new_human_acute_myelocytic_leukemia_cell_line_SH_2_with_a_loss_of_Y_chromosome_a_derivative_chromosome_16_resulting_from_an_unbalanced_translocation_between_chromosomes_16_and_17_monosomy_17_trisomy_19_and_p53_alteration_</link><description>Qiu H, Xu Y, Zhang J, et al. <br/><span class="title">Establishment and characterization of a new human acute myelocytic leukemia cell line SH-2 with a loss of Y chromosome, a derivative chromosome 16 resulting from an unbalanced translocation between chromosomes 16 and 17, monosomy 17, trisomy 19, and p53 alteration. [JOURNAL ARTICLE]</span><br/><span class="source" title="Experimental hematology">Exp Hematol 2008 Aug 18.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18715689/abstract/Establishment_and_characterization_of_a_new_human_acute_myelocytic_leukemia_cell_line_SH_2_with_a_loss_of_Y_chromosome_a_derivative_chromosome_16_resulting_from_an_unbalanced_translocation_between_chromosomes_16_and_17_monosomy_17_trisomy_19_and_p53_alteration_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18715689/full_citation/Establishment_and_characterization_of_a_new_human_acute_myelocytic_leukemia_cell_line_SH_2_with_a_loss_of_Y_chromosome_a_derivative_chromosome_16_resulting_from_an_unbalanced_translocation_between_chromosomes_16_and_17_monosomy_17_trisomy_19_and_p53_alteration_">Full Citation</a></description></item><item><title>[Polymorphisms of RAD51(G135C) and XRCC3(C241T) genes and correlations thereof with prognosis and clinical outcomes of acute myeloid leukemia]</title><link>http://www.unboundmedicine.com/medline/ebm/record/18581889/full_citation/[Polymorphisms_of_RAD51_G135C__and_XRCC3_C241T__genes_and_correlations_thereof_with_prognosis_and_clinical_outcomes_of_acute_myeloid_leukemia]</link><description>Liu L, Yang L, Zhang Y, et al. <br/><span class="title">[Polymorphisms of RAD51(G135C) and XRCC3(C241T) genes and correlations thereof with prognosis and clinical outcomes of acute myeloid leukemia] [English Abstract, Journal Article]</span><br/><span class="source" title="Zhonghua yi xue za zhi">Zhonghua Yi Xue Za Zhi 2008 Feb 5; 88(6):378-82.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18581889/abstract/[Polymorphisms_of_RAD51_G135C__and_XRCC3_C241T__genes_and_correlations_thereof_with_prognosis_and_clinical_outcomes_of_acute_myeloid_leukemia]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18581889/full_citation/[Polymorphisms_of_RAD51_G135C__and_XRCC3_C241T__genes_and_correlations_thereof_with_prognosis_and_clinical_outcomes_of_acute_myeloid_leukemia]">Full Citation</a></description></item><item><title>An improved scoring scheme for predicting glycan structures from gene expression data.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18546491/full_citation/An_improved_scoring_scheme_for_predicting_glycan_structures_from_gene_expression_data_</link><description>Suga A, Yamanishi Y, Hashimoto K, et al. <br/><span class="title">An improved scoring scheme for predicting glycan structures from gene expression data. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Genome informatics. International Conference on Genome Informatics">Genome Inform 2007.:237-46.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18546491/abstract/An_improved_scoring_scheme_for_predicting_glycan_structures_from_gene_expression_data_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18546491/full_citation/An_improved_scoring_scheme_for_predicting_glycan_structures_from_gene_expression_data_">Full Citation</a> | <a href="http://eproceedings.worldscinet.com/cgi-bin/search.cgi%3fid=pii:9781860949920_0023">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18546491/An_improved_scoring_scheme_for_predicting_glycan_structures_from_gene_expression_data_">Find Related Articles</a> </description></item><item><title>CI-994 (N-acetyl-dinaline) in combination with conventional anti-cancer agents is effective against acute myeloid leukemia in vitro and in vivo.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18497959/full_citation/CI_994__N_acetyl_dinaline__in_combination_with_conventional_anti_cancer_agents_is_effective_against_acute_myeloid_leukemia_in_vitro_and_in_vivo_</link><description>Hubeek I, Comijn EM, Van der Wilt CL, et al. <br/><span class="title">CI-994 (N-acetyl-dinaline) in combination with conventional anti-cancer agents is effective against acute myeloid leukemia in vitro and in vivo. [Journal Article]</span><br/><span class="source" title="Oncology reports">Oncol Rep 2008 Jun; 19(6):1517-23.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18497959/abstract/CI_994__N_acetyl_dinaline__in_combination_with_conventional_anti_cancer_agents_is_effective_against_acute_myeloid_leukemia_in_vitro_and_in_vivo_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18497959/full_citation/CI_994__N_acetyl_dinaline__in_combination_with_conventional_anti_cancer_agents_is_effective_against_acute_myeloid_leukemia_in_vitro_and_in_vivo_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18497959/CI_994__N_acetyl_dinaline__in_combination_with_conventional_anti_cancer_agents_is_effective_against_acute_myeloid_leukemia_in_vitro_and_in_vivo_">Find Related Articles</a> </description></item><item><title>Omacetaxine mepesuccinate - a semisynthetic formulation of the natural antitumoral alkaloid homoharringtonine, for chronic myelocytic leukemia and other myeloid malignancies.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18465678/full_citation/Omacetaxine_mepesuccinate___a_semisynthetic_formulation_of_the_natural_antitumoral_alkaloid_homoharringtonine_for_chronic_myelocytic_leukemia_and_other_myeloid_malignancies_</link><description>Quintás-Cardama A, Cortes J <br/><span class="title">Omacetaxine mepesuccinate - a semisynthetic formulation of the natural antitumoral alkaloid homoharringtonine, for chronic myelocytic leukemia and other myeloid malignancies. [Journal Article]</span><br/><span class="source" title="IDrugs : the investigational drugs journal">IDrugs 2008 May; 11(5):356-72.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18465678/abstract/Omacetaxine_mepesuccinate___a_semisynthetic_formulation_of_the_natural_antitumoral_alkaloid_homoharringtonine_for_chronic_myelocytic_leukemia_and_other_myeloid_malignancies_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18465678/full_citation/Omacetaxine_mepesuccinate___a_semisynthetic_formulation_of_the_natural_antitumoral_alkaloid_homoharringtonine_for_chronic_myelocytic_leukemia_and_other_myeloid_malignancies_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18465678/Omacetaxine_mepesuccinate___a_semisynthetic_formulation_of_the_natural_antitumoral_alkaloid_homoharringtonine_for_chronic_myelocytic_leukemia_and_other_myeloid_malignancies_">Find Related Articles</a> </description></item><item><title>Phase I study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced leukemias and myelodysplastic syndromes.</title><link>http://www.unboundmedicine.com/medline/ebm/record/17962510/full_citation/Phase_I_study_of_the_histone_deacetylase_inhibitor_vorinostat__suberoylanilide_hydroxamic_acid_SAHA__in_patients_with_advanced_leukemias_and_myelodysplastic_syndromes_</link><description>Garcia-Manero G, Yang H, Bueso-Ramos C, et al. <br/><span class="title">Phase I study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced leukemias and myelodysplastic syndromes. [JOURNAL ARTICLE]</span><br/><span class="source" title="">Blood 2007 Oct 25.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/17962510/abstract/Phase_I_study_of_the_histone_deacetylase_inhibitor_vorinostat__suberoylanilide_hydroxamic_acid_SAHA__in_patients_with_advanced_leukemias_and_myelodysplastic_syndromes_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/17962510/full_citation/Phase_I_study_of_the_histone_deacetylase_inhibitor_vorinostat__suberoylanilide_hydroxamic_acid_SAHA__in_patients_with_advanced_leukemias_and_myelodysplastic_syndromes_">Full Citation</a> | <a href="http://www.bloodjournal.org/cgi/pmidlookup%3fview=long%26amp;pmid=17962510">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/17962510/Phase_I_study_of_the_histone_deacetylase_inhibitor_vorinostat__suberoylanilide_hydroxamic_acid_SAHA__in_patients_with_advanced_leukemias_and_myelodysplastic_syndromes_">Find Related Articles</a> </description></item><item><title>[Occlusion of the Femoral Arteries in De Novo AML.]</title><link>http://www.unboundmedicine.com/medline/ebm/record/17497090/full_citation/[Occlusion_of_the_Femoral_Arteries_in_De_Novo_AML_]</link><description>Ressel A, Trümper L, Bäsecke J <br/><span class="title">[Occlusion of the Femoral Arteries in De Novo AML.] [JOURNAL ARTICLE]</span><br/><span class="source" title="">Med Klin (Munich) 2007 May; 102(5):388-392.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/17497090/abstract/[Occlusion_of_the_Femoral_Arteries_in_De_Novo_AML_]">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/17497090/full_citation/[Occlusion_of_the_Femoral_Arteries_in_De_Novo_AML_]">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/17497090/[Occlusion_of_the_Femoral_Arteries_in_De_Novo_AML_]">Find Related Articles</a> </description></item><item><title>Risk assessment in haematopoietic stem cell transplantation: Impact of donor-recipient sex combination in allogeneic transplantation.</title><link>http://www.unboundmedicine.com/medline/ebm/record/17448958/full_citation/Risk_assessment_in_haematopoietic_stem_cell_transplantation:_Impact_of_donor_recipient_sex_combination_in_allogeneic_transplantation_</link><description>Gahrton G <br/><span class="title">Risk assessment in haematopoietic stem cell transplantation: Impact of donor-recipient sex combination in allogeneic transplantation. [Journal Article]</span><br/><span class="source" title="Best practice &amp; research. Clinical haematology">Best Pract Res Clin Haematol 2007 Jun; 20(2):219-29.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/17448958/abstract/Risk_assessment_in_haematopoietic_stem_cell_transplantation:_Impact_of_donor_recipient_sex_combination_in_allogeneic_transplantation_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/17448958/full_citation/Risk_assessment_in_haematopoietic_stem_cell_transplantation:_Impact_of_donor_recipient_sex_combination_in_allogeneic_transplantation_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/17448958/Risk_assessment_in_haematopoietic_stem_cell_transplantation:_Impact_of_donor_recipient_sex_combination_in_allogeneic_transplantation_">Find Related Articles</a> </description></item><item><title>Inhibitory effect of curcumin on MDR1 gene expression in patient leukemic cells.</title><link>http://www.unboundmedicine.com/medline/ebm/record/17121181/full_citation/Inhibitory_effect_of_curcumin_on_MDR1_gene_expression_in_patient_leukemic_cells_</link><description>Anuchapreeda S, Thanarattanakorn P, Sittipreechacharn S, et al. <br/><span class="title">Inhibitory effect of curcumin on MDR1 gene expression in patient leukemic cells. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Archives of pharmacal research">Arch Pharm Res 2006 Oct; 29(10):866-73.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/17121181/abstract/Inhibitory_effect_of_curcumin_on_MDR1_gene_expression_in_patient_leukemic_cells_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/17121181/full_citation/Inhibitory_effect_of_curcumin_on_MDR1_gene_expression_in_patient_leukemic_cells_">Full Citation</a></description></item><item><title>Dangerous and Cancer-Causing Properties of Products and Chemicals in the Oil Refining and Petrochemical Industries. Part XXX: Causal Relationship between Chronic Myelogenous Leukemia and Benzene-Containing Solvents.</title><link>http://www.unboundmedicine.com/medline/ebm/record/17119196/full_citation/Dangerous_and_Cancer_Causing_Properties_of_Products_and_Chemicals_in_the_Oil_Refining_and_Petrochemical_Industries__Part_XXX:_Causal_Relationship_between_Chronic_Myelogenous_Leukemia_and_Benzene_Containing_Solvents_</link><description>Mehlman MA <br/><span class="title">Dangerous and Cancer-Causing Properties of Products and Chemicals in the Oil Refining and Petrochemical Industries. Part XXX: Causal Relationship between Chronic Myelogenous Leukemia and Benzene-Containing Solvents. [Journal Article]</span><br/><span class="source" title="Annals of the New York Academy of Sciences">Ann N Y Acad Sci 2006 Sep.:110-9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/17119196/abstract/Dangerous_and_Cancer_Causing_Properties_of_Products_and_Chemicals_in_the_Oil_Refining_and_Petrochemical_Industries__Part_XXX:_Causal_Relationship_between_Chronic_Myelogenous_Leukemia_and_Benzene_Containing_Solvents_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/17119196/full_citation/Dangerous_and_Cancer_Causing_Properties_of_Products_and_Chemicals_in_the_Oil_Refining_and_Petrochemical_Industries__Part_XXX:_Causal_Relationship_between_Chronic_Myelogenous_Leukemia_and_Benzene_Containing_Solvents_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/17119196/Dangerous_and_Cancer_Causing_Properties_of_Products_and_Chemicals_in_the_Oil_Refining_and_Petrochemical_Industries__Part_XXX:_Causal_Relationship_between_Chronic_Myelogenous_Leukemia_and_Benzene_Containing_Solvents_">Find Related Articles</a> </description></item></channel></rss>